{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-064073","form_type":"8-K","ticker":"ALTO","cik":"0000778164","company_name":"Alto Ingredients, Inc.","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.637526+00:00","generated_at":"2026-06-12T05:15:24.566990+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Alto Ingredients posts Q2 net income $7.2M; appoints Bryon McGregor as CEO and Robert Olander as CFO","bullets":["Q2 net sales $317.3M (down 12% YoY); net income $7.2M/$0.10 diluted EPS vs $21.5M/$0.29 incl. $22.7M USDA grant.","Adjusted EBITDA $15.5M vs $29.9M (incl. $22.7M grant); operating income $9.3M vs prior loss of $152,000.","Expects positive adjusted EBITDA in Q3 2023; targets annual EBITDA increase of $125M by end of 2026 via carbon capture and other projects.","Bryon McGregor (former CFO) appointed President/CEO effective Aug 1; Michael Kandris retired as CEO, appointed Interim COO for up to one year.","Robert Olander (former VP, Corporate Controller) appointed CFO effective Aug 1."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-064073","json":"https://secwatch.observer/filing/0001213900-23-064073.json","markdown":"https://secwatch.observer/filing/0001213900-23-064073.md","text":"https://secwatch.observer/filing/0001213900-23-064073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/778164/000121390023064073/0001213900-23-064073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/778164/000121390023064073/ea182962-8k_altoing.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T05:15:24.566990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ce251a8287b0d3ffe132cf44b103ed6ecef23a0","claim":"Alto Ingredients, Inc. updated its the third quarter of 2023 guidance (initiated).","evidence_excerpt":"Based on current trends, we expect to post positive Adjusted EBITDA in the third quarter of 2023 as well.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/778164/000121390023064073/0001213900-23-064073-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter of 2023"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"4bb10618a194a5ab38bcf2f42171efc1c1019d3f","claim":"Alto Ingredients, Inc. reported the six months ended June 30, 2023 results: revenue $631.2 million, net income $6.2 million, EPS $0.08 per diluted share.","evidence_excerpt":"● Net sales were $631.2 million, compared to $670.3 million. ● Cost of goods sold was $617.2 million, compared to $656.7 million. ● Gross profit was $14.0 million, compared to $13.6 million. ● Selling, general and administrative expenses were $15.8 million, compared to $16.6 million. ● Operating loss was $2.4 million, compared to $3.0 million. ● Net loss available to common stockholders was $6.2 million, or $0.08 per diluted share, compared to net income available to common stockholders of $18.6 million, including the $22.7 million USDA cash grant, or $0.26 per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/778164/000121390023064073/0001213900-23-064073-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the six months ended June 30, 2023"},{"label":"Revenue","value":"$631.2 million"},{"label":"Net income","value":"$6.2 million"},{"label":"EPS","value":"$0.08 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"db98be0bc31a0cb40939f59fec437916544ade73","claim":"Alto Ingredients, Inc. reported the quarter ended June 30, 2023 results: revenue $317.3 million, net income $7.2 million, EPS $0.10 per diluted share.","evidence_excerpt":"● Net sales were $317.3 million, compared to $362.2 million. ● Cost of goods sold was $300.1 million, compared to $353.3 million. ● Gross profit was $17.2 million, compared to $8.8 million. ● Selling, general and administrative expenses were $7.9 million, compared to $9.0 million. ● Operating income was $9.3 million, compared to an operating loss of $152,000. 1 ● Net income available to common stockholders was $7.2 million, or $0.10 per diluted share, compared to $21.5 million, which included a $22.7 million USDA cash grant, or $0.29 per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/778164/000121390023064073/0001213900-23-064073-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$317.3 million"},{"label":"Net income","value":"$7.2 million"},{"label":"EPS","value":"$0.10 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"0f6d49e686","claim":"Bryon T. McGregor was appointed as President and Chief Executive Officer at Alto Ingredients, Inc..","evidence_excerpt":"the Board of Directors (the “Board”) of the Company appointed Bryon T. McGregor to serve as the Company’s President and Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/778164/000121390023064073/0001213900-23-064073-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"16cd4257ee","claim":"Robert R. Olander was appointed as Chief Financial Officer at Alto Ingredients, Inc..","evidence_excerpt":"Effective August 1, 2023, the Board appointed Robert R. Olander to serve as the Company’s Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/778164/000121390023064073/0001213900-23-064073-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a7fc8e7891","claim":"Michael D. Kandris was appointed as Interim Chief Operating Officer at Alto Ingredients, Inc..","evidence_excerpt":"On the same date, the Board appointed Mr. Kandris to serve as the Company’s Interim Chief Operating Officer for a period of up to one year.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/778164/000121390023064073/0001213900-23-064073-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"f723687bd8","claim":"Michael D. Kandris retired as President and Chief Executive Officer at Alto Ingredients, Inc..","evidence_excerpt":"Effective August 1, 2023, Michael D. Kandris retired as President and Chief Executive Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/778164/000121390023064073/0001213900-23-064073-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}